RNAi-mediated reversible opening of the blood-brain barrier

Journal of Gene Medicine

Volumn 10, Issue 8, 2008, Pages 930-947

  Campbell, Matthew ^a   Kiang, Anna Sopioa ^a   Kenna, Paul F ^a   Kerskens, Christian ^a   Blau, Chistphn ^a   O'Dwyer, Laurence ^a   Tivnan, Amanda ^a   Kelly, Julie Anne ^a   Brankin, Brenda ^b   Farrar, Gwyneth Jane ^a   Hyumphries, Peter ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Blood brain barrier; Claudin 5; Drug delivery; RNA interference; Tight junctions

Indexed keywords

CLAUDIN 5; MESSENGER RNA; PHOSPHATE; PROTIRELIN; SMALL INTERFERING RNA; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CELL SIZE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HYDRODYNAMICS BASED TRANSFECTION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; TIGHT JUNCTION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TIGHT JUNCTIONS; TIME FACTORS;

MUS;

EID: 49349115993     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1211     Document Type: Article

References (34)

1. Pardridge WM. Molecular biology of the blood-brain barrier. Mol Biotechnol 2005; 30: 57-70.
2. Miller G. Drug targeting. Breaking down barriers. Science 2002; 297: 1116-1118.
3. Pardridge WM. Molecular Trojan horses for blood-brain barrier drug delivery. Curr Opin Pharmacol 2006; 6: 494-500.
4. Spencer BJ, Verma IM. Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci USA 2007; 104: 7594-7599.
5. Kumar P, Wu H, McBride JL, et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007; 448: 39-43. Epub 2007 Jun 17.
6. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967; 34: 207-217.
7. Edwards RH. Drug delivery via the blood-brain barrier. Nat Neurosci 2001; 4: 221-222.
8. Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 2002; 38: 323-337.
9. Matter K, Balda MS. Holey barrier: claudins and the regulation of brain endothelial permeability. J Cell Biol 2003; 161: 459-460.
10. Fanning AS, Anderson JM. PDZ domains and the formation of protein networks at the plasma membrane. Curr Topics Microbiol Immunol 1998; 228: 209-233.
11. Zahraoui A, Louvard D, Galli T. Tight junction, a platform for trafficking and signaling protein complexes. J Cell Biol 2000; 151: F31-36.
12. Bazzoni G. Endothelial tight junctions: permeable barriers of the vessel wall. Thromb Haemost 2006; 95: 36-42.
13. Kausalya PJ, Reichert M, Hunziker W. Connexin45 directly binds to ZO-1 and localizes to the tight junction region in epithelial MDCK cells. FEBS Lett 2001; 505: 92-96.
14. Turksen K, Troy TC. Barriers built on claudins. J Cell Sci 2004; 117: 2435-2447.
15. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161: 653-660.
16. Koto T, Takubo K, Ishida S, et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 2007; 170: 1389-1397.
17. Anderson JM. Molecular structure of tight junctions and their role in epithelial transport. News Physiol Sci 2001; 16: 126-130.
18. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-293.
19. Herweijer H, Wolff JA. Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther 2007; 14: 99-107.
20. Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998; 143: 391-401.
21. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002; 32: 107-108.
22. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature 2002; 418: 38-39.
23. Kiang AS, Palfi A, Ader M, et al. Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach. Mol Ther 2005; 12: 555-561.
24. Hino T, Yokota T, Ito S, et al. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells. Biochem Biophys Res Commun 2006; 340: 263-267.
25. Bickel U, Yoshikawa T, Pardridge WM. Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 2001; 46: 247-279.
26. Schlageter KE, Molnar P, Lapin GD, Groothuis DR. Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Microvasc Res 1999; 58: 312-328.
27. Fontijn RD, Rohlena J, van Marle J, Pannekoek H, Horrevoets AJ. Limited contribution of claudin-5-dependent tight junction strands to endothelial barrier function. Eur J Cell Biol 2006; 85: 1131-1144. Epub 2006 Sep 7.
28. Sirotkin H, Morrow B, Saint-Jore B, et al. Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome. Genomics 1997; 42: 245-251.
29. Scalabrino GA, Hogan N, O'Boyle KM, et al. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone. Neuropharmacology 2007; 52: 1472-81. Epub 2007 Feb 28.
30. Urayama A, Yamada S, Ohmori Y, Deguchi Y, Uchida S, Kimura R. Blood-brain permeability of [3H]-(3-methyl-His2)thyrotropin-releasing hormone (MeTRH) in mice: effects of TRH and its analogues. Drug Metab Pharmacokinet 2003; 18: 310-318.
31. Gan LS, Niederer T, Eads C, Thakker D. Evidence for predominantly paracellular transport of thyrotropin-releasing hormone across CACO-2 cell monolayers. Biochem Biophys Res Commun 1993; 197: 771-777.
32. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330.
33. Palfi A, Ader M, Kiang AS. RNAi-based suppression and replacement of rds-peripherin in retinal organotypic culture. Hum Mutat 2006; 27: 260-268.
34. O'Reilly M, Palfi A, Chadderton N, et al. RNA-interference mediated suppression and replacement of human rhodopsin in vivo. Am J Hum Genet 2007; 81: 127-135. Epub 2007 May 23.